|
DelalutinDrug - Delalutin The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Hydroxyprogesterone Caproate
Strength -
125MG/ML
Applicant -
BRISTOL MYERS SQUIBB
New Drug Application (NDA) Number -
010347
Product Number -
004
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Bristol Myers Squibb
Delalutin
Hydroxychloroquine Sulfate 200mg Tablet; Oral
Hydroxychloroquine Sulfate 200mg Tablet; Oral Hydroxychloroquine Sulfate 200mg Tablet; Oral Hydroxychloroquine Sulfate 200mg Tablet; Oral Plaquenil 200mg Tablet; Oral Delalutin 125mg/ml Injectable; Injection Hydroxomin 1mg/ml Injectable; Injection Paredrine 1% Solution/drops; Ophthalmic Paremyd 1%;0.25% Solution/drops; Ophthalmic Hydroxychloroquine Sulfate 200mg Tablet; Oral NewDrugInformation |